Page 65 - Sohini Das

We've demonstrated our quality & capability to enter US, Europe: SII CEO

80-90% of our global capacity will be in India, says SII CEO Adar Poonawalla

Serum Institute plans pandemic facility to stockpile vax for the world

Adar Poonawalla, CEO and brain behind the new age SII, says in an interaction with Business Standard that by the end of 2021, the company was making 250 million doses a month

We're geared to launch a new molecule every 1-2 years: Biocon Biologics MD

In an interview, Arun Chandavarkar explains why a company must continue investing in R&D despite the impact on short-term Ebitda

We continue to increase our reach and access in India, say Sun Pharma execs

Senior Sun Pharma executives speak on a two-pronged strategy for the China market, beginning R&D of biosimilar products, and more

Torrent group rolls out succession plan; Aman Mehta joins pharma unit board

Last year, Aman had told Business Standard that they were still quite flexible to take up roles within the organisation

Cipla Q1 net dips 4% to Rs 686 cr, revenue down 2% on tapering Covid sales

Domestic revenue dips 8.4% as Covid-19 share of branded prescription business normalises; North American business up 10% to $155 million

Sun Pharma Q1 net up 43% to Rs 2,061 crore on specialty sales, India biz

Gross sales up 10.1% YoY to Rs 10,644 cr; EBITDA at Rs 2,884.4 cr, with a margin of 26.8%

Mylab, firm that makes kits to detect Covid, starts pathology test facility

"We are now getting to 'wet' pathology tests like blood tests etc and we have set up a centre which will have minimal human intervention and maximum automation

Strong India growth boosts DRL Q1 profit by 108% to Rs 1,188 crore

The DRL stock was down marginally (0.73 per cent) to Rs 4,254 on the BSE on Thursday

Bharat Biotech, ExcellGene consortium to develop variant-proof Covid vax

The consortium is developing or designing a new vaccine concept that confers highly cross-reactive protection against numerous SARS-CoV-2 variants of concern

Free Covid-19 vaccination campaign lifted booster dose coverage: Govt

From a daily average of 4.7 lakh doses per day till July 15, the number of precaution shots went up to 20.4 lakh per day (from July 15 till date)

Start-ups collaborate with chemists, shake up offline pharma business

Some are managing supply-chain backend for retail pharmacies, right from stockist to chemist, others are offering telemedicine kiosks at chemist outlets, and digitising pharmacies

India working on indigenous kit to test monkeypox as cases on the rise

At present, 15 VRDLs are equipped to test for monkeypox, including the National Institute of Virology (NIV) in Pune

Centre asks states to increase testing, vaccination amid recent Covid surge

Reviews Covid-19 situation in nine states where test positivity rates have been rising

Torrent Pharma expected to enter diagnostics space in next 2-3 months

A company called Torrent Diagnostics Private Ltd was incorporated in February this year and has a Torrent Pharmaceuticals executive director as one of its directors

Covaxin third shot gives long-term immunity: Nature Scientific study

Study shows booster jab is effective against several Sars-CoV-2 strains such as Alpha, Beta, Delta, Delta Plus and Omicron, and also increases memory B-cell response

Rupee at 80: Neutral impact for India's pharma industry, say experts

India's pharma sector exported drugs worth Rs 1.8 trillion in 2021-22, while APIs worth Rs 30,000 crore were imported

India's rising medical devices imports hurt small and medium units

China accounts for about one-fifth of FY22 numbers; 41% surge overall

Deal with Zoetis could be worth $500 mn in 10 yrs: Syngene In'l chief

In a Q&A, Jonathan Hunt, MD & CEO of the Biocon arm, dwells on his firm's initiatives to overcome supply chain bottlenecks and other issues

Slow and steady: India touches 2 billion Covid-19 vaccine doses milestone

Experts feel heterologous boosting and focus on drugs is the way forward